NR-45905金黄色葡萄球菌,IL(分离物F)(细菌）

NR-45905??Staphylococcus aureus, IL (Isolate F)(Bacteria)|Staphylococcus aureus|IL (Isolate F)||NARSAAcknowledgment for publications should read “The following reagent was provided by the Network on Antimicrobial Resistance in Staphylococcus aureus (NARSA) for distribution by BEI Resources, NIAID, NIH: Staphylococcus aureus, Strain IL (Isolate F), NR-45905.”|Quantity limit per order for this item is 1. This item can be ordered twice a year. Orders over this limit will be sent to NIAID for approval before shipment. Staphylococcus aureus (S. aureus), strain IL [(isolate F) (also referred to as NRS79)] was isolated in Illinois, USA, on April 27, 1999, from a peripheral blood sample of a 63-year-old female with bacteremia and a history of end-stage renal disease, intravascular access, failed arteriovenous grafts, multiple central venous catheter-associated infections and intermittent vancomycin treatment. S. aureus, strain IL (isolate F) is a vancomycin-intermediate S. aureus (VISA) strain and 1 of 6 isolates collected from the paitent during her hospitalizaton.  Strain IL (isolate F) was deposited as positive for mec (subtype II); negative for vanA, vanB, vanC1, vanC2, vanD and vanE; MLST sequence type (ST) 231; eGenomic spa type 2, eGenomic spa repeats TJMBMDMGMK; Ridom spa type t002. Each vial contains approximately 0.5 mL of bacterial culture in Tryptic Soy broth supplemented with 10% glycerol.